Corneal erosion is a common ocular condition that can cause significant pain and discomfort. It is characterized by a loss of the protective outer layer of the cornea, which can lead to sensitivity to light, blurred vision, and foreign body sensation. Recurrent corneal erosion (RCE) is a particularly problematic form of the condition in which the erosion occurs repeatedly. It is estimated that RCE affects between 0.2% and 4.3% of the population, and is more common in people with certain risk factors such as contact lens use, dry eye, and previous ocular surgery. The management of RCE is challenging due to its recurrent nature. Conventional treatments such as the use of topical antibiotics and topical steroids are often ineffective, and the condition can be difficult to control. In recent years, there have been a number of advances in the prevention and treatment of RCE, including the use of newer medications, surgical techniques, and lifestyle modifications. This article will discuss these new strategies for tackling recurrent corneal erosion.
Topical medications are commonly used to treat RCE, and there are a number of newer medications that have been developed in recent years. One of the most commonly used medications is the antibiotic moxifloxacin, which has been shown to reduce the frequency of recurrences. Other antibiotics such as ofloxacin, gatifloxacin, and levofloxacin have also been used with some success. In addition to antibiotics, other medications such as cyclosporine, tacrolimus, and corticosteroids have been used to reduce the inflammation associated with RCE. These medications can be used alone or in combination with antibiotics.
In some cases, surgical techniques may be used to treat RCE. These techniques include phototherapeutic keratectomy (PTK) and debridement. PTK is a procedure in which the affected corneal tissue is removed using a laser. This can reduce the frequency of recurrences and improve symptoms. Debridement is a procedure in which the affected corneal tissue is scraped away using a scalpel. This can help to remove any debris or bacteria that may be causing the erosion.
Lifestyle modifications can also be beneficial in the management of RCE. These include avoiding contact lenses, using artificial tears, and wearing protective eyewear. Contact lenses should be avoided in people with RCE, as they can increase the risk of recurrences. Artificial tears can help to reduce the symptoms associated with RCE, and protective eyewear can help to protect the eyes from further damage.
Recurrent corneal erosion is a challenging condition to manage due to its recurrent nature. There have been a number of advances in the prevention and treatment of RCE in recent years, including the use of newer medications, surgical techniques, and lifestyle modifications. These strategies can help to reduce the frequency of recurrences and improve symptoms. It is important to discuss any treatment options with an ophthalmologist to determine the best course of action.
1.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
2.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
3.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
4.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
5.
Renewing the call for a national Cancer Patient's Bill of Rights
1.
Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells
2.
Tumor Evolution Forecasting for Precision Oncology Decisions
3.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
4.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
5.
Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Managing Common Side Effects During Cancer Treatment
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation